Your browser doesn't support javascript.
loading
MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2.
Kim, Richard Y; Horvat, Jay C; Pinkerton, James W; Starkey, Malcolm R; Essilfie, Ama T; Mayall, Jemma R; Nair, Prema M; Hansbro, Nicole G; Jones, Bernadette; Haw, Tatt Jhong; Sunkara, Krishna P; Nguyen, Thi Hiep; Jarnicki, Andrew G; Keely, Simon; Mattes, Joerg; Adcock, Ian M; Foster, Paul S; Hansbro, Philip M.
  • Kim RY; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Horvat JC; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Pinkerton JW; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Starkey MR; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Essilfie AT; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Mayall JR; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Nair PM; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Hansbro NG; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Jones B; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Haw TJ; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Sunkara KP; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Nguyen TH; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Jarnicki AG; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Keely S; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Mattes J; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Adcock IM; Airways Disease Section, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
  • Foster PS; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia.
  • Hansbro PM; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute and University of Newcastle, Newcastle, Australia. Electronic address: Philip.Hansbro@newcastle.edu.au.
J Allergy Clin Immunol ; 139(2): 519-532, 2017 02.
Article en En | MEDLINE | ID: mdl-27448447

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía / Virus Sincitiales Respiratorios / Infecciones del Sistema Respiratorio / Asma / Haemophilus influenzae / Chlamydia muridarum / MicroARNs / Fosfohidrolasa PTEN / Subtipo H1N1 del Virus de la Influenza A / Histona Desacetilasa 2 Límite: Animals / Humans Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía / Virus Sincitiales Respiratorios / Infecciones del Sistema Respiratorio / Asma / Haemophilus influenzae / Chlamydia muridarum / MicroARNs / Fosfohidrolasa PTEN / Subtipo H1N1 del Virus de la Influenza A / Histona Desacetilasa 2 Límite: Animals / Humans Idioma: En Año: 2017 Tipo del documento: Article